Literature DB >> 22898326

Endothelium-dependent nitroxyl-mediated relaxation is resistant to superoxide anion scavenging and preserved in diabetic rat aorta.

C H Leo1, A Joshi, J L Hart, O L Woodman.   

Abstract

The aim of the study was to investigate whether diabetes-induced oxidant stress affects the contribution of nitroxyl (HNO) to endothelium-dependent relaxation in the rat aorta. Organ bath techniques were employed to determine vascular function of rat aorta. Pharmacological tools (3mM l-cysteine, 5mM 4-aminopyridine (4-AP), 200μM carboxy-PTIO and 100μM hydroxocobalamin, HXC) were used to distinguish between NO and HNO-mediated relaxation. Superoxide anion levels were determined by lucigenin-enhanced chemiluminescence. In the diabetic aorta, where there is increased superoxide anion production, responses to the endothelium-dependent relaxant ACh were not affected when the contribution of NO to relaxation was abolished by either HXC or carboxy-PTIO, indicating a preserved HNO-mediated relaxation. Conversely, when the contribution of HNO was inhibited with l-cysteine or 4-AP, the sensitivity and maximum relaxation to ACh was significantly decreased, suggesting that the contribution of NO was impaired by diabetes. Furthermore, whereas HNO appears to be derived from eNOS in normal aorta, in the diabetic aorta it may also arise from an eNOS-independent source, perhaps derived from nitrosothiol stores. Similarly, exposure to the superoxide anion generator, pyrogallol (100μM) significantly reduced the sensitivity to the NO donor, DEANONOate and ACh-induced NO-mediated relaxation but had no effect on responses to the HNO donor, Angeli's salt and ACh-induced HNO-mediated relaxation in the rat aorta. These findings demonstrate that NO-mediated relaxation is impaired during oxidative stress but the HNO component of relaxation is preserved under those conditions.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898326     DOI: 10.1016/j.phrs.2012.07.010

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  13 in total

1.  Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.

Authors:  Guangshuo Zhu; Dieter Groneberg; Gautam Sikka; Daijiro Hori; Mark J Ranek; Taishi Nakamura; Eiki Takimoto; Nazareno Paolocci; Dan E Berkowitz; Andreas Friebe; David A Kass
Journal:  Hypertension       Date:  2014-12-01       Impact factor: 10.190

2.  Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes.

Authors:  Marianne Tare; Rushita S R Kalidindi; Kristen J Bubb; Helena C Parkington; Wee-Ming Boon; Xiang Li; Christopher G Sobey; Grant R Drummond; Rebecca H Ritchie; Barbara K Kemp-Harper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-10       Impact factor: 3.000

Review 3.  Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.

Authors:  Barbara K Kemp-Harper; John D Horowitz; Rebecca H Ritchie
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

4.  Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects.

Authors:  Sonia Donzelli; Gerry Fischer; Bruce S King; Christin Niemann; Jenna F DuMond; Jörg Heeren; Hartwig Wieboldt; Stephan Baldus; Christian Gerloff; Thomas Eschenhagen; Lucie Carrier; Rainer H Böger; Michael Graham Espey
Journal:  J Pharmacol Exp Ther       Date:  2012-12-04       Impact factor: 4.030

5.  Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin).

Authors:  C H Leo; M Jelinic; H H Ng; M Tare; L J Parry
Journal:  Br J Pharmacol       Date:  2016-02-17       Impact factor: 8.739

6.  Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation.

Authors:  Barbara K Kemp-Harper; Anida Velagic; Nazareno Paolocci; John D Horowitz; Rebecca H Ritchie
Journal:  Handb Exp Pharmacol       Date:  2021

Review 7.  Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction.

Authors:  Chen-Huei Leo; Owen L Woodman
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

8.  Endothelial dysfunction in renal arcuate arteries of obese Zucker rats: The roles of nitric oxide, endothelium-derived hyperpolarizing factors, and calcium-activated K+ channels.

Authors:  Dan-dan Yin; Qian-chen Wang; Xun Zhou; Ying Li
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

9.  Serelaxin Treatment Reduces Oxidative Stress and Increases Aldehyde Dehydrogenase-2 to Attenuate Nitrate Tolerance.

Authors:  Chen Huei Leo; Dhanushke T Fernando; Lillie Tran; Hooi Hooi Ng; Sarah A Marshall; Laura J Parry
Journal:  Front Pharmacol       Date:  2017-03-21       Impact factor: 5.810

10.  Chronic NaHS Treatment Is Vasoprotective in High-Fat-Fed ApoE(-/-) Mice.

Authors:  Asha Ford; Mohammad Al-Magableh; Tracey A Gaspari; Joanne L Hart
Journal:  Int J Vasc Med       Date:  2013-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.